MNPR
NASDAQ · Biotechnology
Monopar Therapeutics Inc
$71.42
+4.20 (+6.25%)
Next Earnings Report
EPS Surprise History
Earnings Summary
Beats (Last 2)
1/2
Avg Surprise
+9.4%
Consecutive Beats
1 quarter
Latest EPS
$-0.46
History
2 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Q3 FY2026 | $-0.63 | — | — | — | — |
| May 14, 2026 | Q2 FY2026 | $-0.85 | $-0.46 | +$0.39 | +46.0% | Beat |
| May 13, 2026 | Q2 FY2026 | $-0.85 | — | — | — | — |
| May 11, 2026 | Q2 FY2026 | $-0.85 | — | — | — | — |
| Mar 30, 2026 | Q1 FY2026 | $-0.50 | — | — | — | — |
| Mar 27, 2026 | Q1 FY2026 | $-0.50 | $-0.64 | -$0.14 | -27.3% | Miss |